Adjunctive Use of Circulating Tumor DNA Testing in Detecting Pancreas Cancer Recurrence (original) (raw)
Circulating Tumor DNA as a Clinical Test in Resected Pancreatic Cancer
Stacy Mosier
Clinical Cancer Research, 2019
View PDFchevron_right
Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers
Michele Yip-schneider
Proceedings of the National Academy of Sciences
View PDFchevron_right
Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review
Luis Sabater
Cancers
View PDFchevron_right
Utility of circulating tumor DNA for predicting prognosis in the management of resectable pancreatic cancer
Journal of Cancer Metastasis and Treatment, Akhil Chawla
Journal of Cancer Metastasis and Treatment, 2022
View PDFchevron_right
Circulating Tumor DNA-Based Testing and Actionable Findings in Patients with Advanced and Metastatic Pancreatic Adenocarcinoma
Pashtoon M Kasi
The Oncologist, 2021
View PDFchevron_right
Plasma Circulating Tumor DNA in Pancreatic Cancer Patients Is a Prognostic Marker
Valerie Taly
Clinical Cancer Research, 2016
View PDFchevron_right
Liquid biopsies in pancreatic cancer
Vahid Bahrambeigi
Journal of Pancreatology, 2019
View PDFchevron_right
Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer
Alfredo Carrato
BMC cancer, 2015
View PDFchevron_right
Liquid biopsy in pancreatic cancer: the beginning of a new era
Dipesh Yadav
Oncotarget
View PDFchevron_right
Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
Jacqui Shaw
Oncotarget
View PDFchevron_right
Circulating Tumor DNA as a Liquid Biopsy for Cancer
Ellen Heitzer
Clinical Chemistry, 2014
View PDFchevron_right
Circulating tumor DNA (ctDNA) as a pan-cancer screening test: is it finally on the horizon?
Michael Duffy
Clinical Chemistry and Laboratory Medicine (CCLM)
View PDFchevron_right
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
Emmanuel Toure
British journal of cancer, 2017
View PDFchevron_right
Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
Pierre Cordelier
Cancers
View PDFchevron_right
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
Leslie Meehan
Cancer Drug Resistance, 2021
View PDFchevron_right
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
Yaqi Li
Scientific Reports, 2019
View PDFchevron_right
Techniques of using circulating tumor DNA as a liquid biopsy component in cancer management
Maha Elazezy
Computational and Structural Biotechnology Journal, 2018
View PDFchevron_right
Evaluation of the diagnostic and prognostic clinical values of circulating tumor DNA and cell-free DNA in pancreatic malignancies: a comprehensive meta-analysis
Mehmet Emin Arayici
Frontiers in oncology, 2024
View PDFchevron_right
Clinical utility of circulating tumor DNA in human cancers
Ellen Heitzer
memo - Magazine of European Medical Oncology, 2015
View PDFchevron_right
Noninvasive cancer biomarkers in solid malignancies: circulating tumor DNA—clinical utility, current limitations and future perspectives
Denis Jardim
Annals of Translational Medicine
View PDFchevron_right
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT) initiative
Craig Heartwell
Oncotarget, 2016
View PDFchevron_right
Valuating Clinical Applications of Liquid Biopsy by Combining Circulating Tumor Dna and Tumor Cells
Keshav Moharir
2022
View PDFchevron_right
Liquid Biopsies for Cancer: Coming to a Patient near You
Ali Torkamani
Journal of Clinical Medicine, 2017
View PDFchevron_right
Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA
Hala Boulos
npj Precision Oncology, 2021
View PDFchevron_right
Detection of Circulating Tumor DNA in Solid Tumors
ugo testa
OBM Genetics, 2020
View PDFchevron_right
Early detection and monitoring of cancer in liquid biopsy: advances and challenges
William Cho
Expert Review of Molecular Diagnostics
View PDFchevron_right
Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
Yusha Araf
2022
View PDFchevron_right
Evaluation of cell-free DNA as a biomarker for pancreatic malignancies
Chiara Bedin
The International Journal of Biological Markers, 2014
View PDFchevron_right
How liquid biopsies can change clinical practice in oncology
Tiziana Venesio
Annals of Oncology, 2019
View PDFchevron_right
Circulating Tumor DNA as a Biomarker for Monitoring Patients with Solid Cancers: Comparison with Standard Protein Biomarkers
Michael Duffy
Clinical Chemistry
View PDFchevron_right